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Abstract Objective Chronic tinnitus is a highly prevalent condition and has been hypothesized to result
from an innate disturbance in central nervous serotonergic transmission. Given the frequent comorbidity with
major depression and anxiety, we argue that candidate genes for these disorders are likely to overlap. The present
study addresses the gene encoding for the 5-HT1A receptor as a putative risk factor for tinnitus. Methods In 88
subjects with a diagnosis of chronic subjective tinnitus who underwent a detailed neurootological examination, the
entire 5-HT1A gene was amplified using overlapping PCR products. Amplicons were custom sequenced
bidirectionally and were screened for variants in multiple alignments against the human genome reference. Results
We identified a synonymous C> T exchange at residue 184 (Pro) in 7/88 subjects, but detected no missense
variants in the population under study. Specifically, the following residues were fully conserved: 16 (Pro), 22(Gly),
28(Ile), 98 (Val), 220(Arg), 267 (Val), 273 (Gly), and 418 (Asn). Discussion The present data count against the
causation of chronic tinnitus by a change in the 5-HT1A receptor's amino acid sequence. However, the allele
frequency for the 184Pro minor allele (0.04) reached twice the frequency reported in control cohorts from the same
ethnicity. Additional investigations are invited to clarify the role of the 5-HT1A polymorphism in larger samples,
and to control for comorbid affective disorders.
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Introduction
Chronic tinnitus is a highly prevalent and often
incapacitating condition that has been estimated to
affect some 130 million Chinese and 40 million
Americans［1，2］. While information from family studies
is still lacking and reliable estimates of the heritability
associated with tinnitus are not currently available,
anecdotal evidence suggests that as many as one-third
of patients may suffer from a familial susceptibility to
the disorder (Kleinjung et al., unpublished data). Given
the frequent co-occurrence of tinnitus and affective
disorders, it has been proposed that some overlap
exists regarding specific vulnerability factors in a
subset of patients. This notion is supported by clinical
benefits experienced by subjects complaining of
chronic tinnitus after the intake of anxiolytic and
antidepressant medication [3].
Specifically, several lines of evidence suggest that
the serotonin receptor 1A (5-HT1A) plays a key role in
modulating susceptibility to affective disorders [4], and
is equally relevant to the processing of auditory stimuli
[5]. 5-HT1A receptors are coupled to G-proteins and
feature seven transmembrane domains. They are
widely expressed throughout the brain, including the
auditory nuclei[6]. In animals, 5-HT1A receptor agonists
control neuronal firing rates in the medial vestibular
nucleus ［7］. Genetic variation in the 5-HT1A gene on
human chromosome 5q11 is associated with the P2
component of auditory evoked potentials in patients
with major depression［８］. In the light of these findings,
we hypothesized that 5-HT1A gene variation may
account for an increased risk of developing chronic
tinnitus and conducted a systematic screening of the
gene in affected individuals.
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Methods
In 88 subjects (63 men and 25 women, age 50.5 ±
13.6 yrs, mean ±SD) a diagnosis of chronic subjective
tinnitus (mean duration 6.6 yrs, range 1-35 yrs) was
confirmed by a detailed neurootological examination
including otoscopy, stapedius reflexes, middle ear pres-
sure measurements, pure tone audiometry, tinnitus
pitch and loudness matches. Those patients with a his-
tory of vestibular schwannoma, Meniere's disease, or
pathological middle ear conditions were excluded. Par-
ticipants in the present study were recruited consecu-
tively at a tinnitus clinic. Tinnitus severity was as-
sessed by the Tinnitus Questionnaire［9］ and averaged
43.4 ±2.3 (mean ±SEM) out of 84 points ( N = 84). By
this measure, tinnitus was considered mild in 29% ,
moderate in 26%, severe in 16%, and extreme in 29%
of subjects investigated. Genomic DNA was extracted
from lymphocytes using standard procedures prior to
amplification of the entire 5-HT1A gene. Two overlap-
ping amplicons were generated (726 and 750bp, respec-
tively) by the following oligomers:
5'-ATTCCCTTCCTCCGAAACTT-3' (forward),
5'-AAAGCTCCAAAGGTGGAATAGATAG-3'(re-
verse), 5‘ -TGCACCATTAGCAAGGATCA-3' (for-
ward), 5'-GGATCCTGTAGCCTCGACTG-3'(reverse).
PCR products were custom sequenced bidirectionally
and were screened for variants in multiple alignments
against the human genome reference(Build 35, chr5
clone RP11-158J3) using Lasergene V4.0(DNAStar
Inc.). Prism V2.01 (GraphPad Software Inc.) was used
for descriptive statistics and for comparison of mean
scores on the Tinnitus Questionnaire (TQ) by unpaired
t-tests.
Results
We identified a synonymous C>T exchange
(SNP-ID #rs1800043, Fig. 1) at residue 184 (Pro) in 7
out of 88 subjects at a frequency of 0.04 for the lesser
T-allele. The genotype distribution did not deviate from
the Hardy-Weinberg equilibrium(p > 0.69, Pearson's χ
2-test). No known or novel missense variants were en-
countered in the population under study(Table 1) and
the following reportedly polymorphic residues were
fully conserved: 16 (Pro), 22 (Gly), 28 (Ile), 98 (Val),
220 (Arg), 267(Val), 273 (Gly), and 418 (Asn). Sub-
jects carrying the T-allele rated their tinnitus as more
severe (mean TQ score = 52.7 ±8.6) than did subjects
carrying only the wild type allele (mean TQ score =
42.7 ±2.3), but this difference did not reach signifi-
cance (p = 0.26, t = 1.14, df = 82).
published 5-HT1A variants
and dbSNP identifiers
C(-1019)G = rs6295
C(-581)A = rs1800048
A(-480)_ = rs1799733
G(-321)C = rs1800047
C(-152)G = rs1800046
T(-51)C = rs1800045
Pro16Leu = rs1800041
Gly22Ser = rs1799920
Ile28Val = rs1799921
Val98Val = rs6294
Pro184Pro = rs1800043
Arg220Leu = rs1800044
Val267Met
Gly273Asp = rs1800042
Asn418Lys
population frequency reported
in the literature
~ 0.50 (Cargill et al., 1999)
< 0.01 (Kawanishi et al., 1998)
< 0.01 (Kawanishi et al., 1998)
< 0.01 (Kawanishi et al., 1998)
< 0.01 (Kawanishi et al., 1998)
< 0.01 (Kawanishi et al., 1998)
~ 0.04 (Kawanishi et al., 1998)
< 0.01 (Nakhai et al., 1995)
< 0.01 (Marshall et al., 1999)
~ 0.11 (Glatt et al., 2004)
~ 0.02 (Glatt et al., 2004)
< 0.01 (Ng et al., 2002)
< 0.01 (Glatt et al., 2004)
~ 0.06 (Sunyaev et al., 2001)
< 0.01 (Lam et al., 1996)
Table 1. Available data on 5-HT1A gene vari⁃
ants including coding variants (shaded rows)
which were systematically screened for in the
present study. Of these, only one variant was
identified (Pro184Pro) in subjects with chronic
tinnitus.
Fig. 1 Chromatograms of the homozygous wildtype
(top) and heterozygous variant(bottom) sequence at
5-HT1A residue 184Pro.
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Discussion
The present data count against the causation of
chronic tinnitus by a change in the 5-HT1A receptor's
amino acid sequence. It cannot be excluded, however,
that the above coding polymorphism is associated with
the disease and is not functionally neutral. Up to one
quarter of synonymous coding variants may lead to
profound changes in splicing patterns[1０], and C/T
transversions are more frequently associated with
human disease than are G/A transversions. This strand
asymmetry has been shown to reflect selective pressure
in four-fold degenerate codons, to which belongs
proline[11]. Alternatively, the variant may be in linkage
disequilibrium with regulatory variants further
upstream of the transcriptional start site. So far, all
previous reports that have addressed prevalence of the
variant T-allele at residue 184 in healthy Caucasians［12,
13］, have provided lower frequencies（f(T) = 0.01 and
f(T) = 0.02, respectively). In healthy Asian individuals,
the allele frequency reported was marginally higher
（f(T) = 0.03,[14]) but did not reach the frequency
ascertained in the present investigation of tinnitus
sufferers. Future studies will therefore need to address
in further detail genotype and allele distributions in
relation to comorbid affective disorders, and to specific
tinnitus etiologies.
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